AstraZeneca
leading late stage pipeline proven execution robust late stage pipeline comprised of both and opportunities continued pipeline momentum with positive pivotal trials in and catalyst rich ongoing late stage clinical trials across our pipeline unique in late stage development potential blockbuster opportunities from potential phase trials planned in | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
July 2023
Slide
8 of 44
Related slides by other companies
AbCellera
Investor Presentation
February 2024
a potential first in class antibody therapy for metabolic and endocrine conditions | AbCellera
BenevolentAI
Investor Conference
January 2024
our pipeline products are highly differentiated | BenevolentAI
SoftBank
Results
November 2023
public listings and late stage pipeline robust late stage portfolio listings | SoftBank
BenevolentAI
Results
March 2024
our pipeline products are highly differentiated | BenevolentAI
Other recent decks by AstraZeneca
See all presentations (27 decks)
Results
February 2024
Investor Conference
January 2024
Results
November 2023
Investor Event
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io